Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 14 Show results per page	View Search Criteria \| Help With Results


1.		Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				20 to 75				Pharmaceutical / Industry				01023010 / TOP-003 NCT00284258


2.		A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				20 to 75				Other				JCOG9912 C000000062, NCT00142350


3.		Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				Pharmaceutical / Industry				SC101 NCT00202969


4.		IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Temporarily closed				18 to 75				Other				HGCSG0601 IFOX study, NCT00316745


5.		Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over				Pharmaceutical / Industry				TPU-S1101; ID02-694 NCT00072787


6.		Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Temporarily closed				20 to 75				Other				HGCSG0405 GEMS-1, NCT00209677

Last Modified: 6/1/2000 First Published: 9/1/1999


7.		Phase II Study of S-1 in Patients With Locally Advanced, Metastatic, or Unresectable Gastric or Colorectal Cancer (Summary Last Modified 06/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				EORTC-16972C/G TAIHO-EORTC-16972C/G

Last Modified: 4/20/2007 First Published: 9/23/2005


8.		Phase II Study of S-1 as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer Previously Treated With Gemcitabine

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				QUINT-TPU-S1201 TAIHO-QUINT-TPU-S1201, NCT00227604

Last Modified: 6/30/2006 First Published: 9/23/2005


9.		Phase II Study of S-1 and Cisplatin as First-Line Therapy in Patients With Unresectable Stage IIIB or IV Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				QUINT-TPU-S1202 TAIHO-QUINT-TPU-S1202, NCT00227578

Last Modified: 12/14/2006 First Published: 9/23/2005


10.		Phase II Study of S-1 as Second-Line Therapy in Patients With Unresectable or Recurrent Stage IIIB or IV Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				QUINT-TPU-S1203 TAIHO-QUINT-TPU-S1203, NCT00227552

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute